SARTORIUS STEDIM BIOTECH (56S1.DE) Stock Fundamental Analysis
Europe - FRA:56S1 - FR0013154002 - Common Stock
187.15 EUR
-0.15 (-0.08%)
56S1 gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 19 industry peers in the Life Sciences Tools & Services industry. Both the profitability and the financial health of 56S1 get a neutral evaluation. Nothing too spectacular is happening here. 56S1 shows excellent growth, but is valued quite expensive already.
1. Profitability
1.1 Basic Checks
56S1 had positive earnings in the past year.
56S1 had a positive operating cash flow in the past year.
In the past 5 years 56S1 has always been profitable.
In the past 5 years 56S1 always reported a positive cash flow from operatings.
1.2 Ratios
56S1 has a worse Return On Assets (2.71%) than 73.68% of its industry peers.
56S1 has a worse Return On Equity (5.63%) than 68.42% of its industry peers.
56S1's Return On Invested Capital of 4.60% is on the low side compared to the rest of the industry. 56S1 is outperformed by 68.42% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for 56S1 is above the industry average of 7.28%.
The 3 year average ROIC (10.41%) for 56S1 is well above the current ROIC(4.60%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.71% | ||
| ROE | 5.63% | ||
| ROIC | 4.6% |
ROA(3y)7.81%
ROA(5y)9.13%
ROE(3y)17.3%
ROE(5y)20.06%
ROIC(3y)10.41%
ROIC(5y)14.57%
1.3 Margins
With a Profit Margin value of 7.78%, 56S1 perfoms like the industry average, outperforming 47.37% of the companies in the same industry.
56S1's Profit Margin has declined in the last couple of years.
The Operating Margin of 56S1 (14.71%) is comparable to the rest of the industry.
56S1's Operating Margin has declined in the last couple of years.
The Gross Margin of 56S1 (44.63%) is better than 63.16% of its industry peers.
In the last couple of years the Gross Margin of 56S1 has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.71% | ||
| PM (TTM) | 7.78% | ||
| GM | 44.63% |
OM growth 3Y-22.38%
OM growth 5Y-9.98%
PM growth 3Y-24.01%
PM growth 5Y-17.3%
GM growth 3Y-6.9%
GM growth 5Y-3.53%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so 56S1 is still creating some value.
The number of shares outstanding for 56S1 has been increased compared to 1 year ago.
Compared to 5 years ago, 56S1 has more shares outstanding
Compared to 1 year ago, 56S1 has an improved debt to assets ratio.
2.2 Solvency
56S1 has an Altman-Z score of 3.85. This indicates that 56S1 is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 3.85, 56S1 is doing good in the industry, outperforming 78.95% of the companies in the same industry.
The Debt to FCF ratio of 56S1 is 5.98, which is a neutral value as it means it would take 56S1, 5.98 years of fcf income to pay off all of its debts.
56S1 has a Debt to FCF ratio of 5.98. This is comparable to the rest of the industry: 56S1 outperforms 47.37% of its industry peers.
A Debt/Equity ratio of 0.71 indicates that 56S1 is somewhat dependend on debt financing.
56S1's Debt to Equity ratio of 0.71 is on the low side compared to the rest of the industry. 56S1 is outperformed by 63.16% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.71 | ||
| Debt/FCF | 5.98 | ||
| Altman-Z | 3.85 |
ROIC/WACC0.55
WACC8.32%
2.3 Liquidity
A Current Ratio of 1.91 indicates that 56S1 should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.91, 56S1 is in the better half of the industry, outperforming 73.68% of the companies in the same industry.
A Quick Ratio of 1.18 indicates that 56S1 should not have too much problems paying its short term obligations.
The Quick ratio of 56S1 (1.18) is worse than 63.16% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.91 | ||
| Quick Ratio | 1.18 |
3. Growth
3.1 Past
56S1 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 25.91%, which is quite impressive.
The Earnings Per Share has been growing slightly by 4.19% on average over the past years.
The Revenue has been growing slightly by 5.44% in the past year.
The Revenue has been growing by 14.05% on average over the past years. This is quite good.
EPS 1Y (TTM)25.91%
EPS 3Y-22.3%
EPS 5Y4.19%
EPS Q2Q%38.82%
Revenue 1Y (TTM)5.44%
Revenue growth 3Y-1.25%
Revenue growth 5Y14.05%
Sales Q2Q%5.46%
3.2 Future
The Earnings Per Share is expected to grow by 22.23% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 10.45% on average over the next years. This is quite good.
EPS Next Y27.61%
EPS Next 2Y23.83%
EPS Next 3Y23.3%
EPS Next 5Y22.23%
Revenue Next Year9.03%
Revenue Next 2Y9.51%
Revenue Next 3Y10.23%
Revenue Next 5Y10.45%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 45.31, 56S1 can be considered very expensive at the moment.
Based on the Price/Earnings ratio, 56S1 is valued expensively inside the industry as 84.21% of the companies are valued cheaper.
The average S&P500 Price/Earnings ratio is at 27.34. 56S1 is valued rather expensively when compared to this.
A Price/Forward Earnings ratio of 34.87 indicates a quite expensive valuation of 56S1.
56S1's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. 56S1 is more expensive than 78.95% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.86. 56S1 is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 45.31 | ||
| Fwd PE | 34.87 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, 56S1 is valued expensively inside the industry as 84.21% of the companies are valued cheaper.
Based on the Price/Free Cash Flow ratio, 56S1 is valued a bit more expensive than the industry average as 63.16% of the companies are valued more cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 36.69 | ||
| EV/EBITDA | 27.63 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
56S1's earnings are expected to grow with 23.30% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.64
PEG (5Y)10.8
EPS Next 2Y23.83%
EPS Next 3Y23.3%
5. Dividend
5.1 Amount
56S1 has a yearly dividend return of 0.36%, which is pretty low.
56S1's Dividend Yield is comparable with the industry average which is at 0.69.
Compared to an average S&P500 Dividend Yield of 2.44, 56S1's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.36% |
5.2 History
The dividend of 56S1 has a limited annual growth rate of 4.44%.
Dividend Growth(5Y)4.44%
Div Incr Years0
Div Non Decr Years1
5.3 Sustainability
56S1 pays out 29.77% of its income as dividend. This is a sustainable payout ratio.
56S1's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP29.77%
EPS Next 2Y23.83%
EPS Next 3Y23.3%
FRA:56S1 (10/13/2025, 7:00:00 PM)
187.15
-0.15 (-0.08%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners11.07%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap18.22B
Analysts81.11
Price Target239.46 (27.95%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.36% |
Yearly Dividend0.71
Dividend Growth(5Y)4.44%
DP29.77%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)16.2%
Min EPS beat(2)10.22%
Max EPS beat(2)22.18%
EPS beat(4)3
Avg EPS beat(4)8.6%
Min EPS beat(4)-5.62%
Max EPS beat(4)22.18%
EPS beat(8)3
Avg EPS beat(8)-10.02%
EPS beat(12)3
Avg EPS beat(12)-13.27%
EPS beat(16)5
Avg EPS beat(16)-12.35%
Revenue beat(2)2
Avg Revenue beat(2)1.91%
Min Revenue beat(2)0.3%
Max Revenue beat(2)3.52%
Revenue beat(4)3
Avg Revenue beat(4)0.4%
Min Revenue beat(4)-5.11%
Max Revenue beat(4)3.52%
Revenue beat(8)5
Avg Revenue beat(8)-0.72%
Revenue beat(12)5
Avg Revenue beat(12)-1.47%
Revenue beat(16)8
Avg Revenue beat(16)12%
PT rev (1m)0.4%
PT rev (3m)1.05%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1.15%
EPS NY rev (1m)0%
EPS NY rev (3m)2.93%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.36%
Revenue NY rev (1m)-1.33%
Revenue NY rev (3m)0.5%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 45.31 | ||
| Fwd PE | 34.87 | ||
| P/S | 6.29 | ||
| P/FCF | 36.69 | ||
| P/OCF | 23.11 | ||
| P/B | 4.55 | ||
| P/tB | N/A | ||
| EV/EBITDA | 27.63 |
EPS(TTM)4.13
EY2.21%
EPS(NY)5.37
Fwd EY2.87%
FCF(TTM)5.1
FCFY2.73%
OCF(TTM)8.1
OCFY4.33%
SpS29.76
BVpS41.13
TBVpS-4.66
PEG (NY)1.64
PEG (5Y)10.8
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.71% | ||
| ROE | 5.63% | ||
| ROCE | 5.78% | ||
| ROIC | 4.6% | ||
| ROICexc | 5.12% | ||
| ROICexgc | 15.67% | ||
| OM | 14.71% | ||
| PM (TTM) | 7.78% | ||
| GM | 44.63% | ||
| FCFM | 17.14% |
ROA(3y)7.81%
ROA(5y)9.13%
ROE(3y)17.3%
ROE(5y)20.06%
ROIC(3y)10.41%
ROIC(5y)14.57%
ROICexc(3y)10.84%
ROICexc(5y)15.37%
ROICexgc(3y)26.31%
ROICexgc(5y)36.49%
ROCE(3y)13.07%
ROCE(5y)18.3%
ROICexcg growth 3Y-36.77%
ROICexcg growth 5Y-16.49%
ROICexc growth 3Y-43.34%
ROICexc growth 5Y-25.09%
OM growth 3Y-22.38%
OM growth 5Y-9.98%
PM growth 3Y-24.01%
PM growth 5Y-17.3%
GM growth 3Y-6.9%
GM growth 5Y-3.53%
F-Score7
Asset Turnover0.35
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.71 | ||
| Debt/FCF | 5.98 | ||
| Debt/EBITDA | 3.84 | ||
| Cap/Depr | 93.43% | ||
| Cap/Sales | 10.07% | ||
| Interest Coverage | 2.82 | ||
| Cash Conversion | 106.77% | ||
| Profit Quality | 220.28% | ||
| Current Ratio | 1.91 | ||
| Quick Ratio | 1.18 | ||
| Altman-Z | 3.85 |
F-Score7
WACC8.32%
ROIC/WACC0.55
Cap/Depr(3y)182.98%
Cap/Depr(5y)186.68%
Cap/Sales(3y)13.87%
Cap/Sales(5y)12.23%
Profit Quality(3y)126.76%
Profit Quality(5y)109.63%
High Growth Momentum
Growth
EPS 1Y (TTM)25.91%
EPS 3Y-22.3%
EPS 5Y4.19%
EPS Q2Q%38.82%
EPS Next Y27.61%
EPS Next 2Y23.83%
EPS Next 3Y23.3%
EPS Next 5Y22.23%
Revenue 1Y (TTM)5.44%
Revenue growth 3Y-1.25%
Revenue growth 5Y14.05%
Sales Q2Q%5.46%
Revenue Next Year9.03%
Revenue Next 2Y9.51%
Revenue Next 3Y10.23%
Revenue Next 5Y10.45%
EBIT growth 1Y7.47%
EBIT growth 3Y-23.35%
EBIT growth 5Y2.67%
EBIT Next Year92.67%
EBIT Next 3Y37.11%
EBIT Next 5Y27.7%
FCF growth 1Y202.01%
FCF growth 3Y7.94%
FCF growth 5Y22.24%
OCF growth 1Y16.41%
OCF growth 3Y5.11%
OCF growth 5Y21.32%